Whether a defective incretin system in T2DM is caused by decreased responsiveness of β cells to GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), or by hyposecretion of incretin hormones, remains unclear. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.